Serious Infection in Inflammatory Bowel Diseases Patients Treated With Vedolizumab, Ustekinumab, Janus Kinase Inhibitors, Anti–Tumor Necrosis Factor or Aminosalicylates

Clinical Gastroenterology and Hepatology 2026

View at publisher

Authors: Anaïs Bertrand, Aurélien Amiot, Antoine Martin, Franck Carbonnel, Antoine Meyer

DOI: 10.1016/j.cgh.2026.04.015

Cited by: 1

References: 29

Fields of Study & Subjects

Inflammatory Bowel Disease Autoimmune and Inflammatory Disorders Microscopic Colitis

References 29